in’t Hout, Florentien E.M., Thessa N. Scheele, Theresia M. Westers, Canan Alhan, Carolien Duetz, Eline M.P. Cremers, Heleen A. Visser-Wisselaar, Annelies Verbrugge, Dana A. Chitu, Bert A. van der Reijden, Aniek O. de Graaf, Arjan A. van de Loosdrecht, and Joop H. Jansen. 2020. “Expression Levels of Genes Implicated in the Working Mechanism of Lenalidomide Predict Treatment Response in Lower Risk Myelodysplastic Syndrome Patients”. Haematologica, September. Pavia, Italy. https://doi.org/10.3324/haematol.2024.286157.